Sales Growth YoY (Last 12 Months): Harpoon Therapeutics (HARP)

Public company logo of Harpoon Therapeutics Corp (HARP)

A strategic alliance with industry leaders strengthens the position of Harpoon Therapeutics (HARP) in solid tumor therapy. The rolling year-over-year relative revenue change confirms the resilience of the model, where the 15.90 level serves as a critical benchmark. Margin stability is ensured by precision cold-chain logistics for components, while integration into a major pharmaceutical behemoth accelerates the development of trispecific antibodies, mitigating pricing risks during the research stage.

Harpoon Therapeutics, Inc. (HARP) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 02/20/2024

Harpoon Therapeutics, Inc. (HARP) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Harpoon Therapeutics
Product sample of harpoontx.com

This indicator calculates trailing twelve-month (TTM) revenue dynamics, neutralizing short-term fluctuations to assess the fundamental stability of the business amid a market downturn. By analyzing the TTM sales volume change, an investor determines the margin of safety for Harpoon Therapeutics (HARP), which is supported by the international status of its oncology research and a strategic partnership with a US pharma behemoth.

Competitors of Harpoon Therapeutics (HARP)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|sonnetbio.com (SONN) - Sales Growth YoY (Last Twelve Months)|MAIA Biotechnology Inc (MAIA) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) liminatuspharma.com|Sales Growth YoY (Last Twelve Months) LVTX|Revenue Growth YoY (Last 12 Months) NXTC (NextCure, Inc.)|LPTX: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Trailing Twelve Months Revenue Growth|TOVX: Revenue Growth YoY (Last 12 Months)|Gritstone bio - Revenue Change YoY (Last 12 Months)|Kineta Bio (KA) - Sales Growth YoY (Last Twelve Months)|NexImmune Inc (NEXI) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) Turnstone Biologics Corp.|Sales Growth YoY (Last 12 Months) VCNX (Vaccinex, Inc.)